These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1275249)

  • 21. Inhibition of spinach D-glyceraldehyde 3-phosphate: NADP+ oxidoreductase (nonphosphorylating) by adenylate compounds: the effect of dead-end inhibitors on a steady state random reaction mechanism.
    Trost P; Pupillo P
    Arch Biochem Biophys; 1993 Oct; 306(1):76-82. PubMed ID: 8215424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic analysis of the L-ornithine transcarbamoylase from Pseudomonas savastanoi pv. phaseolicola that is resistant to the transition state analogue (R)-N delta-(N'-sulfodiaminophosphinyl)-L-ornithine.
    Templeton MD; Reinhardt LA; Collyer CA; Mitchell RE; Cleland WW
    Biochemistry; 2005 Mar; 44(11):4408-15. PubMed ID: 15766270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress-curve equations for reversible enzyme-catalysed reactions inhibited by tight-binding inhibitors.
    Szedlacsek SE; Ostafe V; Duggleby RG; Serban M; Vlad MO
    Biochem J; 1990 Feb; 265(3):647-53. PubMed ID: 2306205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylcholinesterase. I. A study by nuclear magnetic resonance of the binding of inhibitors to the enzyme.
    Kato G
    Mol Pharmacol; 1972 Sep; 8(5):575-81. PubMed ID: 5083614
    [No Abstract]   [Full Text] [Related]  

  • 25. Two-step inhibition of Bacillus cereus penicillinase by dicloxacillin.
    Strom R; Renzini G; Ravagnan G; Rossi Fanelli F
    FEBS Lett; 1974 Jul; 43(1):49-52. PubMed ID: 4212494
    [No Abstract]   [Full Text] [Related]  

  • 26. Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors.
    Morrison JF
    Biochim Biophys Acta; 1969; 185(2):269-86. PubMed ID: 4980133
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetics of the two-sited enzyme. II. A method of distinguishing between anticooperative and independent active sites based on competitive inhibition.
    Harper ET
    J Theor Biol; 1973 Apr; 39(1):91-102. PubMed ID: 4200408
    [No Abstract]   [Full Text] [Related]  

  • 28. Kinetics of inhibition of leukocyte 12-lipoxygenase by the isoform-specific inhibitor 4-(2-oxapentadeca-4-yne)phenylpropanoic acid.
    Moody JS; Marnett LJ
    Biochemistry; 2002 Aug; 41(32):10297-303. PubMed ID: 12162745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermolecular ligand substitution reactions.
    Jenkins WT
    Prog Clin Biol Res; 1984; 144B():89-96. PubMed ID: 6718418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of eukaryotic ribonuclease P activity by aminoglycosides: kinetic studies.
    Tekos A; Tsagla A; Stathopoulos C; Drainas D
    FEBS Lett; 2000 Nov; 485(1):71-5. PubMed ID: 11086168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
    Cheng Y; Prusoff WH
    Biochem Pharmacol; 1973 Dec; 22(23):3099-108. PubMed ID: 4202581
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of bound enzymes. II. Characterization of product inhibition and accumulation.
    Engasser JM; Horvath C
    Biochemistry; 1974 Sep; 13(19):3849-54. PubMed ID: 4413889
    [No Abstract]   [Full Text] [Related]  

  • 33. A new approach in the kinetics of biological transport. The potential of reversible inhibition studies.
    Devés R; Krupka RM
    Biochim Biophys Acta; 1978 Jun; 510(1):186-200. PubMed ID: 667035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient-phase and steady-state kinetics for inhibited enzyme systems. I. Single-intermediate mechanisms.
    Hijazi NH; Laidler KJ
    Can J Biochem; 1973 Jun; 51(6):815-21. PubMed ID: 4717066
    [No Abstract]   [Full Text] [Related]  

  • 35. Half-time analysis of the kinetics of irreversible enzyme inhibition by an unstable site-specific reagent.
    Topham CM
    Biochim Biophys Acta; 1988 Jun; 955(1):65-76. PubMed ID: 3382673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic mechanisms of polyphosphate glucokinase from Mycobacterium tuberculosis.
    Hsieh PC; Kowalczyk TH; Phillips NF
    Biochemistry; 1996 Jul; 35(30):9772-81. PubMed ID: 8703950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An interpretation of partially competitive inhibition of the esterase activity of carboxypeptidase A.
    Bunting JW; Myers CD
    Biochim Biophys Acta; 1974 Mar; 341(1):222-31. PubMed ID: 4857249
    [No Abstract]   [Full Text] [Related]  

  • 38. Kinetics of enzymes with iso-mechanisms: analysis of product inhibition.
    Rebholz KL; Northrop DB
    Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):355-60. PubMed ID: 7980736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hexokinase of human erythrocytes. Purification, kinetic model and its application to the conditions in the cell.
    Gerber G; Preissler H; Heinrich R; Rapoport SM
    Eur J Biochem; 1974 Jun; 45(1):39-52. PubMed ID: 4421639
    [No Abstract]   [Full Text] [Related]  

  • 40. Alternative substrate and inhibition kinetics of aminoglycoside nucleotidyltransferase 2''-I in support of a Theorell-Chance kinetic mechanism.
    Gates CA; Northrop DB
    Biochemistry; 1988 May; 27(10):3826-33. PubMed ID: 2841976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.